Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ecstasy and its "counterparts"].

M Galliot-Guilley1, C Sueur, B Lebeau

  • 1Laboratoire de Biochimie Toxicologie, Hôpital Fernand Widal, Paris.

Presse Medicale (Paris, France : 1983)
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cobalt Stabilization through Mesopore Confinement on TiO<sub>2</sub> Support for Fischer-Tropsch Reaction.

ACS applied energy materials·2023
Same author

Genome sequence and description of <i>Coprococcus phoceensis</i> gen. nov., sp. nov., a new bacterial genus isolated from the human left colon.

New microbes and new infections·2019
Same author

Corrigendum to '"Mediterranea massiliensis" gen. nov., sp. nov., a new human-associated bacteria isolated from the right and left colon lavage of a 58-year-old patient'.

New microbes and new infections·2019
Same author

Genome sequence and description of <i>Traorella massiliensis</i> gen. nov., sp. nov., a new bacterial genus isolated from human left colon.

New microbes and new infections·2019
Same author

Noncontiguous finished genome sequences and description of <i>Bacteroides mediterraneensis</i> sp. nov., <i>Bacteroides ihuae</i> sp. nov., <i>Bacteroides togonis</i> sp. nov., <i>Bacteroides ndongoniae</i> sp. nov., <i>Bacteroides ilei</i> sp. nov. and <i>Bacteroides congonensis</i> sp. nov. identified by culturomics.

New microbes and new infections·2018
Same author

Noncontiguous finished genome sequence and description of <i>Mediterranea massiliensis</i> gen. nov., sp. nov., a new member of the <i>Bacteroidaceae</i> family isolated from human colon.

New microbes and new infections·2018

The use of "ecstasy" (a generic term for various psychostimulants) is a growing public health concern, especially among young people at techno events. Chemical analysis reveals highly variable and often dangerous formulations, necessitating risk awareness and continuous monitoring.

Area of Science:

  • Forensic Chemistry
  • Public Health
  • Toxicology

Context:

  • The recreational use of psychostimulants, often referred to as "ecstasy," is increasing in France, particularly within the techno music scene.
  • This trend poses a significant public health challenge, primarily affecting young individuals who are often unaware of the associated risks.
  • A lack of precise knowledge regarding the chemical composition of these substances hinders effective risk communication and harm reduction strategies.

Purpose:

  • To investigate the chemical composition of substances commonly found at "techno" dances.
  • To assess the risks associated with the use of these psychostimulants.
  • To inform public health strategies for risk awareness and harm reduction.

Summary:

  • Chemical analysis, including rapid colorimetric tests and more elaborate methods, was employed to identify and quantify compounds in illicit drug samples.

Related Experiment Videos

  • Analysis of 73 samples revealed highly variable compositions, with 22% containing methylenedioxyamphetamines (MDMA).
  • The study highlights the extreme danger posed by the diverse and often unknown toxicities of substances circulating in these environments.

    • Impact:

    • Provides crucial data on the chemical landscape of recreational drug use at electronic music events.
    • Emphasizes the urgent need for continuous monitoring and accurate information dissemination to protect public health.
    • Supports the development of targeted harm reduction interventions for vulnerable populations.